NCT02352935View on ClinicalTrials.gov

Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 1, 2020

Study Completion Date

January 1, 2021

Conditions
Hepatic Carcinoma
Interventions
DEVICE

NanoKnife LEDC System

90 pulses of 70 microseconds each in duration will be administered per electrode pair

Trial Locations (1)

510665

FUDA Cancer Hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02352935 - Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function | Biotech Hunter | Biotech Hunter